Title
Category
Credits
Event date
Cost
The Weight is Over: Time to Address Obesity in Type 2 Diabetes Management
  • Weight Management
  • Diabetes Mellitus (DM)
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
$0.00
This virtual activity is designed to help clinicians simultaneously address weight management and glycemic control in patients with type 2 diabetes (T2DM). Along with didactic instruction, the activity will include small group case-study discussions to provide practice in identifying and treating patients who would benefit from a weight-centric approach to type 2 diabetes management, ultimately improving outcomes of patients affected by this complex, chronic disease.
Approaching Weight Management as an Integral Component of T2DM Management
  • Weight Management
  • Diabetes Mellitus (DM)
  • 0.33 AANP Contact Hours
  • 0.15 AANP Pharmacology Contact Hours
  • 0.25 AMA PRA Category 1 Credit™
$0.00
Understanding the relationship between type 2 diabetes mellitus (T2DM) and obesity is key to effectively helping patients reach their treatment goals. Through interactive learning, this activity explores the therapeutic advantages of weight loss in T2DM and how you can best apply current guideline recommendations when choosing personalized therapies. 
Weight Management for Transgender Patients
  • LGBTQ
  • Weight Management
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
$0.00
Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.
Pharmacologic and Medical Advances in Obesity Management
  • Pharmacology
  • Weight Management
  • 15.00 AMA PRA Category 1 Credit™
  • 15.00 ANCC
$105.00
Obesity is a chronic, progressive, relapsing, multifactorial disease resulting in metabolic and biomechanical morbidities and premature mortality, and its prevalence has risen to unacceptable levels in the United States and worldwide. Healthy diet, exercise, and behavioral interventions are crucial components of management but are largely unsuccessful in achieving and maintaining weight reduction sufficient to reduce morbidities and prevent premature mortality because the chronic neuroendocrine disease of obesity remains unaddressed.